Login

TI Ref No :	529222217
Description :	Conclusion Of Non-exclusive Agreements On Medicines Containing The Active Ingredient Relugolix (atc Code: L02bx04) Through An Open-house Model
Date :	2026-02-20
Deadline :	2026-05-19
Document Type :	Tenders